Endo International plc announced the appointment of Domenic Ciarico as Executive Vice President and Chief Commercial Officer, Sterile and Generics, effective immediately. In this role, Mr. Ciarico will lead commercial strategy and execution for Endo's Generics Pharmaceutical and Sterile Injectable businesses which are marketed and sold under the Par Pharmaceutical brand. He will report to Paul Campanelli, President and Chief Executive Officer, and will join the company's Executive Leadership Team. Most recently, Mr. Ciarico served as Senior Vice President and General Manager of Par Sterile Products where he was responsible for all aspects of the U.S. sterile product business which delivered double-digit growth under his leadership. Mr. Ciarico succeeds Tony Pera, President, Par Pharmaceutical, who announced his retirement in April 2019. Prior to joining Endo, Mr. Ciarico spent 20 years with AmerisourceBergen Corporation.